All In Biotech

Drug Trial Radar · NCT03052127

Study in Subjects With Small Primary Choroidal Melanoma

A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma

Last checked: Nov 19, 2026Latest source record: Feb 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

57

Actual

Start

Feb 27, 2017

Primary completion

Jan 26, 2021

Study completion Jan 26, 2021

Sponsor

Lead sponsor
Aura BiosciencesIndustry
Sponsor type
Industry
First posted
Feb 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.

Conditions

  • Uveal Melanoma
  • Ocular Melanoma
  • Choroidal Melanoma

Interventions

  • Light-activated AU-011Drug

    Study treatment

  • Laser ActivationDevice

    Study treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Events [Safety and Tolerability] of Light-activated AU-011Time frame: Informed consent through 1-2 years

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Retina Associates SW, P.C.

    Tucson, Arizona

  • UCLA Jules Stein Eye Institute

    Los Angeles, California

  • Byers Eye Institute at Stanford University

    Palo Alto, California

  • Retina Consultants of Sacramento

    Sacramento, California

  • Colorado Retina Associates

    Denver, Colorado

  • Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

  • W. K. Kellogg Eye Center, University of Michigan

    Ann Arbor, Michigan

  • Associated Retinal Consultants, PC

    Royal Oak, Michigan

  • Retina Center

    Minneapolis, Minnesota

  • Columbia University Medical Center

    New York, New York

  • Wills Eye Hospital

    Philadelphia, Pennsylvania

  • Retina Consultants of Carolina, PA

    Greenville, South Carolina

  • Retina Consultants of Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.